Tumour angiogenesis factor (TAF) and its neutralisation by a xenogeneic antiserum
- 15 January 1979
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 23 (1), 82-88
- https://doi.org/10.1002/ijc.2910230115
Abstract
Tumour angiogenesis factor (TAF) has been extracted from a variety of animal and human tumours. Its ability to induce neovascularization in two bioassays, viz. rat air-sac and chick chorio-allantoic membrane, is demonstrated. Similar extracts from normal tissues fail to induce angiogenesis. TAF extracts have been used to raise a xenogeneic antiserum, the specificity of which was investigated using classical immunological methods. Its ability to neutralize the biological activity of TAF using the two in vivo assays, was also demonstrated.Keywords
This publication has 9 references indexed in Scilit:
- Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombinThe Journal of cell biology, 1978
- Tumour angiogenesis and tumour immunityPublished by Springer Science and Business Media LLC ,1978
- Factors from 3T3 cells stimulate proliferation of cultured vascular endothelial cellsNature, 1977
- Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary HyperplasiaScience, 1977
- Tumour angiogenesis factor (TAF) in human and animal tumoursInternational Journal of Cancer, 1976
- Endothelial growth factor present in tissue culture of CNS tumorsJournal of Neurosurgery, 1976
- Tumor AngiogenesisAdvances in Cancer Research, 1974
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISThe Journal of Experimental Medicine, 1971
- Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic TransplantsJNCI Journal of the National Cancer Institute, 1945